Variant report

Variant	nsv528155
Chromosome Location	chr9:93106543-93152717
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:8)
LncRNA
region (count:6)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:57914932..57916732-chr9:93116621..93119481,2	MCF-7	breast:
2	chr1:45195117..45197029-chr9:93118640..93120158,2	K562	blood:
3	chr9:93103277..93106203-chr9:93118468..93120864,2	MCF-7	breast:
4	chr9:93102527..93105084-chr9:93106529..93108300,2	K562	blood:
5	chr9:93140741..93143322-chr9:93148992..93151722,2	K562	blood:
6	chr9:93141218..93144173-chr9:93173013..93175871,2	MCF-7	breast:
7	chr1:45185888..45187495-chr9:93118658..93120159,2	K562	blood:
8	chr9:93140741..93143322-chr9:93148992..93151722,2	K562	blood:

(count:6 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DIRAS2-2	chr9:93147298-93147865	XLOC_007769
2	lnc-DIRAS2-2	chr9:93147298-93147564	XLOC_007769
3	lnc-DIRAS2-2	chr9:93145799-93146003	NONHSAT133001
4	lnc-DIRAS2-2	chr9:93145892-93146003	XLOC_007769
5	lnc-DIRAS2-2	chr9:93145802-93146003	NR_109795
6	lnc-DIRAS2-2	chr9:93145978-93146003	XLOC_007769

No data

Variant related genes	Relation type
ENSG00000200169	chromatin interactions
ENSG00000062716	chromatin interactions

Extended variants
information (count: 1409 )
Associated
traits (count: 73 )

Variant overlapped rSNPs/rCNVs (count:1409 , 50 per page) page: 1 2 3 4 5 6 7 ... 29

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs979814	chr9:93106543-93106544	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs570218040	chr9:93106614-93106615	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs34057964	chr9:93106625-93106626	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs187447605	chr9:93106630-93106631	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs555631610	chr9:93106716-93106717	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs979815	chr9:93106722-93106723	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
7	rs369999318	chr9:93106748-93106749	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs979816	chr9:93106801-93106802	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
9	rs192579866	chr9:93106828-93106829	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs553013081	chr9:93106882-93106883	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs75110264	chr9:93106937-93106938	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs543382930	chr9:93106945-93106946	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs576279530	chr9:93106953-93106954	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs563358670	chr9:93106975-93106976	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs563862324	chr9:93106978-93106979	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs531339568	chr9:93107032-93107033	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs556068688	chr9:93107074-93107075	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs368913310	chr9:93107114-93107115	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs118034567	chr9:93107160-93107161	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs12235218	chr9:93107191-93107192	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs72741360	chr9:93107262-93107263	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs559435544	chr9:93107292-93107293	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs541884438	chr9:93107319-93107320	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs561549508	chr9:93107323-93107324	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs199851390	chr9:93107324-93107325	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs573112906	chr9:93107327-93107328	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs528282194	chr9:93107328-93107329	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs201104766	chr9:93107330-93107331	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs201913639	chr9:93107331-93107332	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs10993092	chr9:93107332-93107333	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs184920994	chr9:93107344-93107345	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs564954335	chr9:93107352-93107353	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs542365441	chr9:93107365-93107366	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs188987423	chr9:93107378-93107379	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs550552079	chr9:93107381-93107382	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs567254154	chr9:93107386-93107387	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs180887143	chr9:93107432-93107433	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs566277879	chr9:93107433-93107434	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs183946768	chr9:93107449-93107450	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs555682133	chr9:93107467-93107468	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs560434017	chr9:93107506-93107507	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs112517250	chr9:93107510-93107511	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs557027449	chr9:93107546-93107547	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs189410426	chr9:93107549-93107550	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs373545387	chr9:93107550-93107551	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs573975915	chr9:93107596-93107597	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs542699620	chr9:93107597-93107598	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs2798038	chr9:93107606-93107607	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs114265192	chr9:93107649-93107650	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs545198133	chr9:93107717-93107718	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:73)

Disease	PMID	Source
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Medulloblastoma	21979893	CNVD
microdeletion syndrome	16199537	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
Urothelial carcinoma	21177765	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Myelofibrosis	22110671	CNVD
lymphocytic leukemia	21291569	CNVD
Leukemia	17361228	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Glioblastoma	16823260	CNVD
Leukemia	18688285	CNVD
Non-small cell lung cancer	21044232	CNVD
Brain cancer	20823417	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Renal cell carcinoma	19461508	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Heart disease	21282601	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute myeloid leukemia	21251322	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	17603634	CNVD
Acute myeloid leukemia	20729466	CNVD
Oral cancer	21386901	CNVD
Bipolar disorder	18458673	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	18632612	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Gastric cancer	17908304	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Biliary cancer	19435499	CNVD
small cell lung cancer	20016488	CNVD
Intracranial aneurysm	16715129	CNVD
Cardiac fibroma	18329553	CNVD
Mental retardation	21693067	CNVD
Glioma	17123091	CNVD
Mantle cell lymphoma	19029149	CNVD
Breast cancer	17133270	CNVD
Basal cell nevus syndrome	21572526	CNVD
Mental retardation	19951919	CNVD
Retinoblastoma	22278416	CNVD
9q22.3 microdeletion syndrome	22283845	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:87 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:93103000-93107600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr9:93103000-93111400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr9:93105200-93108400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
4	chr9:93105600-93106600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
5	chr9:93105600-93107200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
6	chr9:93105600-93107200	Enhancers	HMEC	breast
7	chr9:93105600-93107200	Enhancers	HSMMtube	muscle
8	chr9:93105600-93108000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
9	chr9:93105600-93108400	Enhancers	NHEK	skin
10	chr9:93105800-93106600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
11	chr9:93105800-93106600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
12	chr9:93105800-93107200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
13	chr9:93106000-93106600	Enhancers	Brain Germinal Matrix	brain
14	chr9:93106000-93106800	Enhancers	HUES64 Cell Line	embryonic stem cell
15	chr9:93106200-93106600	Enhancers	ES-I3 Cell Line	embryonic stem cell
16	chr9:93106200-93106600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
17	chr9:93106200-93106600	Enhancers	H9 Cell Line	embryonic stem cell
18	chr9:93106200-93106600	Enhancers	iPS-18 Cell Line	embryonic stem cell
19	chr9:93106200-93106600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
20	chr9:93106200-93106600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
21	chr9:93106200-93106800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
22	chr9:93106200-93107200	Enhancers	Breast Myoepithelial Primary Cells	Breast
23	chr9:93106400-93106800	Weak transcription	Muscle Satellite Cultured Cells	--
24	chr9:93106400-93107000	Weak transcription	HSMM	muscle
25	chr9:93106400-93107200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
26	chr9:93106400-93107600	Weak transcription	Esophagus	oesophagus
27	chr9:93106400-93111800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
28	chr9:93106600-93108200	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
29	chr9:93106600-93109600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
30	chr9:93106600-93109600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
31	chr9:93106600-93110000	Weak transcription	H9 Cell Line	embryonic stem cell
32	chr9:93106800-93107200	Enhancers	Muscle Satellite Cultured Cells	--
33	chr9:93107000-93107200	Enhancers	A549	lung
34	chr9:93107000-93107200	Enhancers	HSMM	muscle
35	chr9:93107200-93108200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
36	chr9:93107600-93108400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
37	chr9:93107800-93108000	Enhancers	Esophagus	oesophagus
38	chr9:93108200-93108400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
39	chr9:93108200-93109600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
40	chr9:93108400-93109800	Weak transcription	NHEK	skin
41	chr9:93109600-93110000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
42	chr9:93109600-93110200	Enhancers	ES-I3 Cell Line	embryonic stem cell
43	chr9:93109600-93110400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
44	chr9:93109600-93110400	Enhancers	HUES6 Cell Line	embryonic stem cell
45	chr9:93109800-93110000	Enhancers	NHEK	skin
46	chr9:93110000-93110200	Enhancers	H9 Cell Line	embryonic stem cell
47	chr9:93111400-93111600	Strong transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
48	chr9:93111400-93112200	Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
49	chr9:93111600-93112400	Enhancers	Pancreas	Pancrea
50	chr9:93111600-93112600	ZNF genes & repeats	H1 Derived Mesenchymal Stem Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links